[Serologic breast cancer follow-up monitoring using pregnancy-associated alpha-2-glycoproteins].
The variations in serum level of the alpha 2-PAG (pregnancy associated glycoprotein) were studied during the treatment of 25 patients with breast cancer. A good correlation was found between alpha 2-PAG concentration and the course of the disease. Serum alpha 2-Pag levels rose prior to the clinical recognition of metastatic disease and decreased significantly on successful treatment. alpha 2-PAG appears to have potential as an indicator of the growth of micrometastases.
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000097:blood* / Q000601:surgery; D005260:Female; D006801:Humans; D008408:Mastectomy; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011379:Prognosis; D000511:alpha-Macroglobulins / Q000032:analysis*
D000511:alpha-Macroglobulins
Serologische Mammacarcinomverlaufskontrolle mit Hilfe des schwangerschaftsassoziierten alpha-2-Glykoproteins.